Robot-assisted radiotherapy represents a significant leap forward in the treatment of eye diseases. Published in The Lancet, a pioneering trial underscores its potential by showing substantial reductions in the necessity for injections to manage conditions, potentially cutting global injection needs by up to 1.8 million annually.
Recent data released by the Centers for Disease Control and Prevention (CDC) challenges prior assumptions about the prevalence of Chronic Fatigue Syndrome (CFS), shedding light on its broader impact on more than 3 million Americans. The findings, derived from a comprehensive analysis, suggest that this serious, long-term illness, also known as myalgic encephalomyelitis (ME/CFS), is more common than previously thought.